Penn I
Arch Otolaryngol. 1975 Nov;101(11):667-70. doi: 10.1001/archotol.1975.00780400025007.
The immune system is an important factor in the host's defenses against cancer. Immunosuppressive therapy associated with organ transplantation is accompanied by a substantially increased incidence of malignant neoplasms, many of which involve the head and neck. Treatment of carcinoma of the larynx by excision and laryngeal transplantation is not justified because of the complications, including malignant neoplasm, that are associated with immunosuppressive therapy. Cancer chemotherapeutic agents have immunosuppressive side-effects, and patients have manifested new malignant neoplasms while their original tumors were controlled by the antineoplastic drugs. These findings have important implications for the management of patients with malignant neoplasms, since other forms of cancer treatment, such as radical surgical procedures and radiotherapy, may also impair the host's resistance to cancer. Therefore, we should reappraise our methods of cancer therapy and examine their effects on the host's resistance to his neoplasm.
免疫系统是宿主抵御癌症的重要因素。与器官移植相关的免疫抑制疗法伴随着恶性肿瘤发病率的大幅上升,其中许多涉及头颈部。由于与免疫抑制疗法相关的并发症(包括恶性肿瘤),通过切除和喉移植治疗喉癌是不合理的。癌症化疗药物具有免疫抑制副作用,并且患者在其原发肿瘤被抗肿瘤药物控制时出现了新的恶性肿瘤。这些发现对恶性肿瘤患者的管理具有重要意义,因为其他形式的癌症治疗,如根治性手术和放疗,也可能损害宿主对癌症的抵抗力。因此,我们应该重新评估我们的癌症治疗方法,并检查它们对宿主抵抗肿瘤的影响。